about
Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsDisrupting the networks of cancerMethyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosisSynthetic lethal screening with small-molecule inhibitors provides a pathway to rational combination therapies for melanoma.Melanoma: a model for testing new agents in combination therapies.Opportunities and challenges in the development of experimental drug combinations for cancer.Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug AdministrationThe evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.Hedgehog signaling in prostate cancer and its therapeutic implicationFeedback Regulation in a Cancer Stem Cell Model can Cause an Allee Effect.Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours.Personalized therapies in the cancer "omics" eraPotential synergies for combined targeted therapy in the treatment of neuroendocrine cancer.In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.A systematic analysis of FDA-approved anticancer drugs.Managing drug resistance in cancer: lessons from HIV therapy
P2860
Q28305100-43CBD2BE-701F-487F-82CA-727DAF41924EQ28656016-D7E65BAB-A776-4DA1-8882-1070A1BB3BC6Q28658683-0A439043-8ED4-4FC3-9184-7B299520B025Q30416651-EABFC433-FD55-43D2-ABEA-92F789BFE9E5Q33863916-CE398CD9-54FD-4D23-B399-7E1B4597A414Q35555293-EABF19B3-A479-4FA5-8902-2626262B6D9CQ36565598-6C009B82-75D3-46B4-9144-068E89DB92C4Q37075845-B26876F4-74AB-4E38-9737-8EBD7E1D604BQ37091887-553DF173-8BD0-4CA7-9710-C44CB677C46BQ37097913-C033DA65-7D3E-49B9-9AF3-A81BBA2CE48AQ37287413-9062549D-E251-4279-BB16-9B905E48326FQ37776547-A6BD3828-EAFF-401D-B4A5-2D3788BE7488Q37875054-7F9131BF-94DE-44C5-847D-07CD09AB02FBQ38680891-F6C7C8F5-5935-4452-8E95-6D096FD056E2Q42276844-19A7A11C-C33E-4AF0-8C32-049ED8577038Q57340028-FDB5E6F4-1229-41B4-9ECE-BF51DC030646
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Targeted agents: the rules of combination.
@en
type
label
Targeted agents: the rules of combination.
@en
prefLabel
Targeted agents: the rules of combination.
@en
P2093
P1476
Targeted agents: the rules of combination.
@en
P2093
Bruce Chabner
Eunice L Kwak
Jeffrey W Clark
P304
P356
10.1158/1078-0432.CCR-07-1385
P407
P433
P577
2007-09-01T00:00:00Z